🇺🇸 FDA
Patent

US 6291501

Compounds and methods of use for treatment of neurogenic inflammation

expired A61KA61K31/4178A61K31/497

Quick answer

US patent 6291501 (Compounds and methods of use for treatment of neurogenic inflammation) held by The Regents of the University of California expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/4178, A61K31/497